ORBSEN THERAPEUTICS LIMITED

Country

Ireland

Type

Beneficiary

Grants received

8

Funding record

• 8 grants on record
• €4,056,143.40 awarded in total
• 2008–2016 span of the record

Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.

Programmes

• Seventh Framework Programme 4 grants · €2,700,366.85
• Horizon 2020 Framework Programme 2 grants · €845,287.50

2 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.

Frequent partners

Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.

• UNIVERSITY OF GALWAY 7 shared projects · 2008–2016 · Ireland
• PINTAIL LTD 6 shared projects · 2008–2016 · Ireland
• ACADEMISCH ZIEKENHUIS LEIDEN 2 shared projects · 2012–2015 · Netherlands
• CHARITE - UNIVERSITAETSMEDIZIN BERLIN 2 shared projects · 2012–2014 · Germany
• LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN 2 shared projects · 2012–2015 · Germany
• NHS BLOOD AND TRANSPLANT 2 shared projects · 2014–2015 · United Kingdom
• THE QUEEN'S UNIVERSITY OF BELFAST 2 shared projects · 2012–2015 · United Kingdom
• THE UNIVERSITY OF BIRMINGHAM 2 shared projects · 2013–2014 · United Kingdom

Calls from this organisation

No published calls from this organisation.

Grants received

• Development of Biomaterial-based Delivery Systems for Parkinson’s disease - an Integrated Pan-European Approach €265,674.60 · awarded 1 January 2016 · from European Commission
• Development of closed, scalable and AUTOmated robotic systems for therapeutic STEM cell manufacturing: aseptic systems from “Donor-to-Patient” €448,375 · awarded 1 January 2016 · from European Commission
• Novel Stromal Cell Therapy for Diabetic Kidney Disease €396,912.50 · awarded 1 May 2015 · from European Commission
• Adverse Immune Signatures and their Prevention in Corneal Transplantation €451,319.85 · awarded 1 April 2014 · from European Commission
• MEsenchymal stem cells to Reduce Liver INflammation €931,516 · awarded 1 February 2014 · from European Commission
• Decision-making within cells and differentiation entity therapies €244,814.45 · awarded 1 March 2013 · from European Commission
• Repair of Diabetic Damage by Stromal Cell Administration €1,061,896 · awarded 1 November 2012 · from European Commission
• Utilisation of the mesenchymal stem cell receptome for rational development of uniform, serum-free culture conditions and tools for cell characterization €255,635 · awarded 1 November 2008 · from European Commission